Skip to main content
INCY
NASDAQ Life Sciences

$2B Acquisition Expands Incyte's Blood Disorder Pipeline

Reported by Reuters
Sentiment info
Positive
Importance info
8
Price
$102.83
Mkt Cap
$20.544B
52W Low
$66.74
52W High
$112.29
Market data snapshot near publication time

Summary

Incyte announced it will acquire Vega Therapeutics for up to $2 billion, significantly expanding its pipeline for blood disorder therapies. This strategic acquisition strengthens Incyte's position in a key therapeutic area. The article also noted Johnson & Johnson's previously reported $1 billion acquisition of Firefly Bio to expand its oncology pipeline.

At the time of this announcement, INCY was trading at $102.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.5B. The 52-week trading range was $66.74 to $112.29. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

INCY - Latest Insights

INCY
Jun 08, 2026, 9:34 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $102.83
Real-time Price: $101.72 info
Change: -$1.11 (-1%) info
Market Cap: $20.322B info
INCY
Jun 08, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $102.07
Real-time Price: $101.72 info
Change: -$0.350 (-0.34%) info
Market Cap: $20.322B info
INCY
Jun 08, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $102.07
Real-time Price: $101.72 info
Change: -$0.350 (-0.34%) info
Market Cap: $20.322B info
INCY
May 30, 2026, 8:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $96.74
Real-time Price: $101.72 info
Change: +$4.98 (+5%) info
Market Cap: $20.322B info
INCY
May 20, 2026, 8:45 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $96.00
Real-time Price: $101.72 info
Change: +$5.72 (+6%) info
Market Cap: $20.322B info
INCY
May 01, 2026, 5:48 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $97.10
Real-time Price: $101.72 info
Change: +$4.62 (+5%) info
Market Cap: $20.322B info
INCY
Apr 28, 2026, 4:25 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $96.20
Real-time Price: $101.72 info
Change: +$5.52 (+6%) info
Market Cap: $20.322B info
INCY
Apr 28, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $96.20
Real-time Price: $101.72 info
Change: +$5.52 (+6%) info
Market Cap: $20.322B info
INCY
Apr 28, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $92.00
Real-time Price: $101.72 info
Change: +$9.72 (+11%) info
Market Cap: $20.322B info
INCY
Mar 28, 2026, 3:00 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $90.30
Real-time Price: $101.72 info
Change: +$11.42 (+13%) info
Market Cap: $20.322B info